Literature DB >> 23608084

Warfarin for thromboprophylaxis following total joint arthroplasty: are patients safely anti-coagulated?

Michael Aynardi1, P Benedict Brown, Zachary Post, Fabio Orozco, Alvin Ong.   

Abstract

The purpose of this study was to investigate whether any correlation exists between INR level at discharge and postoperative complications or readmission rates. From 2010-2011, INR levels on discharge, complications and readmissions within 30 days were recorded on 441 patients undergoing joint arthroplasty. Eighty percent (352 of 441) patients had a subtherapeutic INR level at discharge. The overall complication rate was 15% with an 8.6% readmission rate. A supratherapeutic INR level at discharge was associated with both higher readmission rate as well as increased number of complications (P<0.048). Most patients taking warfarin are nontherapeutic at the time of discharge; notably, a supratherapeutic INR places patients at risk for increased complications and readmissions rates following surgery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  International Normalized Ratio (INR); complications; joint replacement; thromboprophylaxis; warfarin

Mesh:

Substances:

Year:  2013        PMID: 23608084     DOI: 10.1016/j.arth.2012.12.007

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  The use of warfarin for DVT prophylaxis following hip and knee arthroplasty: how often are patients within their target INR range?

Authors:  Denis Nam; Anita Sadhu; Jeffrey Hirsh; James A Keeney; Ryan M Nunley; Robert L Barrack
Journal:  J Arthroplasty       Date:  2014-09-06       Impact factor: 4.757

2.  Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.

Authors:  Brian F Gage; Anne R Bass; Hannah Lin; Scott C Woller; Scott M Stevens; Noor Al-Hammadi; Jeffrey L Anderson; Juan Li; Tomás Rodriguez; J Philip Miller; Gwendolyn A McMillin; Robert C Pendleton; Amir K Jaffer; Cristi R King; Brandi Whipple; Rhonda Porche-Sorbet; Lynnae Napoli; Kerri Merritt; Anna M Thompson; Gina Hyun; Wesley Hollomon; Robert L Barrack; Ryan M Nunley; Gerard Moskowitz; Victor Dávila-Román; Charles S Eby
Journal:  JAMA       Date:  2019-09-03       Impact factor: 56.272

3.  Assessment of Dosing and Patient Factors on the Efficacy of Warfarin Following Total Joint Replacement.

Authors:  Ryan Murphy; Annamarie Stehli; Hiep Nguyen; Szu-Yun Leu; Danh V Nguyen; Ran Schwarzkopf
Journal:  Open Orthop J       Date:  2015-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.